Company Profile
Waters Corporation Stock Price, News & Analysis
- Ticker:
- WAT
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
399.70 USD (-0.08%)
Close
Last updated: August 6, 2026
36.5B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, WAT was little changed and closed at $399.70. No new same-company headline was identified in the current news window.
Company overview
Business overview
Waters Corporation is a life sciences tools company focused on analytical instruments, chromatography, mass spectrometry, and related laboratory workflows. It supports the research and quality-control infrastructure behind pharma and biotech development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Waters has a global footprint in laboratory tools and analytical systems. It sits in scientific instrumentation rather than biotech therapeutics.
Business Model Characteristics
The company generates revenue through instruments, recurring consumables, and service. Investors watch lab spending, pharma capital budgets, and the health of research and quality-control demand.
Position Within the Biotechnology Landscape
Waters sits in the biotech tools layer, where it benefits from research and lab activity across the life sciences ecosystem. It is not a drug stock, but it is tightly connected to the industry’s investment cycle.
Future catalysts
Waters’ near-term catalysts are bioprocessing demand, chromatography spending, and instrument replacement cycles in pharma labs. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name ahead of the following catalyst.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Waters Corporation (WAT)?
Waters Corporation (WAT) most recently closed at 399.70 USD, a -0.08% move versus the previous session.
What is the market cap of Waters Corporation (WAT)?
Waters Corporation currently has a market capitalization of 36.5B USD on BioPharmSignal.
What does Waters Corporation do?
Waters Corporation is a life sciences tools company focused on analytical instruments, chromatography, mass spectrometry, and related laboratory workflows. It supports the research and quality-control infrastructure behind pharma and biotech development.
On which exchange is WAT stock listed?
Waters Corporation (WAT) is associated with NYSE, United States, Biopharma.
What is Waters?
Waters’ near-term catalysts are bioprocessing demand, chromatography spending, and instrument replacement cycles in pharma labs.
Which conditions is Waters Corporation targeting with Waters?
Waters’ near-term catalysts are bioprocessing demand, chromatography spending, and instrument replacement cycles in pharma labs.
How does Waters Corporation describe recent progress with Waters?
Waters’ near-term catalysts are bioprocessing demand, chromatography spending, and instrument replacement cycles in pharma labs.
What is Corporation?
Waters Corporation is a life sciences tools company focused on analytical instruments, chromatography, mass spectrometry, and related laboratory workflows.